Cited by 1,000MicroRNA in disease regulationMetabolism, Diabetes, and CancerAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

MicroRNAs 103 and 107 regulate insulin sensitivity

Open access

Trajkovski, Mirko, Hausser, Jean, Soutschek, Jürgen, Bhat, Bal, Akin, Akinc, Zavolan, Mihaela, Heim, Markus H., Stoffel, Markus·2011·Nature

DOI 10.1038/nature10112

Open this paper in CoChat — free account Open PDF

Abstract

Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10112

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citation
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,529
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591

Show all 27 references

Sorted by citations

Items 401–500 of 996

Emerging roles of the myocardin family of proteins in lipid and glucose metabolism
Swärd, K., Stenkula, K. G., Rippe, C., Alajbegovic, A., Gomez, M. F., & Albinsson, S. (2016) · The Journal of Physiology · doi:10.1113/jp271913 · Cited by 40
miRNAs in Heart Development and Disease
Lozano-Velasco, E., Inácio, J. M., Sousa, I., Guimarães, A. R., Franco, D., Moura, G. R., & Belo, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031673 · Cited by 42
Comprehensive miRNome and in silico analyses identify the Wntsignaling pathway to be altered in the diabetic liver
Kaur, K., Pandey, A. K., Srivastava, S. P., Srivastava, R., & Datta, M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05041a · Cited by 39
Micro RNA 152 regulates hepatic glycogenesis by targeting PTEN
Wang, S., Wang, L., Dou, L., Guo, J., Fang, W., Li, M., Meng, X., Man, Y., Shen, T., Huang, X., et al. (2016) · FEBS Journal · doi:10.1111/febs.13713 · Cited by 38
miR-1275 inhibits adipogenesis via ELK1 and its expression decreases in obese subjects
Pang, L., You, L., Ji, C., Shi, C., Chen, L., Yang, L., Huang, F., Zhou, Y., Zhang, J., Chen, X., et al. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0007 · Cited by 38
New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis–Related Kidney Disease
Musso, G., Michieli, F. D., Bongiovanni, D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Gambino, R., Cassader, M., Cohney, S. J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.002 · Cited by 38
Regulation of Gene Expression by Exercise-Related Micrornas
Masi, L. N., Serdan, T. D. A., Levada‐Pires, A. C., Hatanaka, E., Silveira, L. R., Cury‐Boaventura, M. F., Pithon‐Curi, T. C., Curi, R., Gorjão, R., & Hirabara, S. M. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452507 · Cited by 39
Endothelial miRNAs as Cellular Messengers in Cardiometabolic Diseases
Njock, M., & Fish, J. E. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.009 · Cited by 38
Dynamic changes of epigenetic signatures during chondrogenic and adipogenic differentiation of mesenchymal stem cells
Saidi, N., Ghalavand, M., Hashemzadeh, M. S., Dorostkar, R., Mohammadi, H., & Mahdian-shakib, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.093 · Cited by 38
Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?
Gracia, A., Fernández‐Quintela, A., Miranda, J., Eseberri, I., González, M. A., & Portillo, M. P. (2017) · Nutrients · doi:10.3390/nu9040360 · Cited by 38
Identification of miR‐305, a micro RNA that promotes aging, and its target mRNA s in Drosophila
Ueda, M., Sato, T., Ohkawa, Y., & Inoue, Y. H. (2018) · Genes to Cells · doi:10.1111/gtc.12555 · Cited by 38
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
Characterization of mi R ‐210 in 3 T 3‐ L 1 adipogenesis
Liang, W., Wang, Y., Wan, D. C., Yeung, V. S. Y., & Waye, M. M. Y. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24617 · Cited by 38
microRNAs involved in Parkinson's disease: A systematic review
da Silva, F. C., Iop, R. D. R., Vietta, G. G., Kair, D. A., Filho, P. J. B. G., Alvarenga, J. G., & da Silva, R. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5759 · Cited by 39
Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats
Vatandoost, N., Amini, M., Iraj, B., Momenzadeh, S., & Salehi, R. (2015) · Gene · doi:10.1016/j.gene.2015.07.015 · Cited by 37
Expression of genes for micro RNA ‐processing enzymes is altered in advanced non‐alcoholic fatty liver disease
Sharma, H., Estep, M., Birerdinc, A., Afendy, A., Moazzez, A. H., Elariny, H. A., Goodman, Z. D., Chandhoke, V., Baranova, A. V., & Younossi, Z. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12268 · Cited by 37
MiR-301a Mediates the Effect of IL-6 on the AKT/GSK Pathway and Hepatic Glycogenesis by Regulating PTEN Expression
Dou, L., Wang, S., Sui, X., Meng, X., Shen, T., Huang, X., Guo, J., Fang, W., Man, Y., Xi, J., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373962 · Cited by 37
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease
Neppl, R. L., & Wang, D. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.003 · Cited by 36
MicroRNA Dysregulation in Liver and Pancreas of CMP-Neu5Ac Hydroxylase Null Mice Disrupts Insulin/PI3K-AKT Signaling
Kwon, D., Chang, B., & Kim, J. (2014) · BioMed Research International · doi:10.1155/2014/236385 · Cited by 38
MicroRNA-494, Upregulated by Tumor Necrosis Factor-α, Desensitizes Insulin Effect in C2C12 Muscle Cells
Lee, H., Jee, Y., Hong, K., Hwang, G. S., & Chun, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083471 · Cited by 38
miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice
Marchand, A., Atassi, F., Mougenot, N., Clergue, M., Codoni, V., Berthuin, J., Proust, C., Trégouët, D., Hulot, J., & Lompré, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.010 · Cited by 39
Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract
Xu, P., Dai, S., Wang, J., Zhang, J., Liu, J., Wang, F., & Zhai, Y. (2016) · Scientific Reports · doi:10.1038/srep19659 · Cited by 39
MicroRNA and Diabetic Complications: A Clinical Perspective
Fan, B., Luk, A. O. Y., Chan, J. C. N., & Ronald, C. W. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7318 · Cited by 37
Comprehensive network of miRNA-induced intergenic interactions and a biological role of its core in cancer
Galatenko, V., Galatenko, A. V., Samatov, T. R., Turchinovich, A. A., Shkurnikov, M. Y., Makarova, J. A., & Tonevitsky, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20215-5 · Cited by 40
Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans
Ma, E., Fu, Y., & Garvey, W. T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0101 · Cited by 37
MicroRNA regulated macrophage activation in obesity
Li, C., Qu, L., Farragher, C., Vella, A. T., & Zhou, B. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0011 · Cited by 38
Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
Ideozu, J. E., Zhang, X., Rangaraj, V. R., McColley, S. A., & Levy, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-51890-7 · Cited by 37
microRNA-27a-3p but Not -5p Is a Crucial Mediator of Human Adipogenesis
Wu, H., Pula, T., Tews, D., Amri, E., Debatin, K., Wabitsch, M., Fischer‐Posovszky, P., & Roos, J. (2021) · Cells · doi:10.3390/cells10113205 · Cited by 39
The Role of miRNAs in Metabolic Diseases
Mačvanin, M., Obradovic, M. M., Zafirovic, S. S., Stanimirović, J., & Isenović, E. R. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220801161536 · Cited by 40
Molecular Targets of Omega 3 and Conjugated Linoleic Fatty Acids – “Micromanaging” Cellular Response
Visioli, F., Giordano, E., Nicod, N. M., & Dávalos, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00042 · Cited by 38
Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies
Ullah, M. I., & Tamanna, S. (2025) · Medicines · doi:10.3390/medicines12030019 · Cited by 38
“• MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
CryomiRs: Towards the identification of a cold-associated family of microRNAs
Lyons, P. J., Lang-Ouellette, D., & Morin, P. (2013) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2013.10.001 · Cited by 36
Differential expression of miRNAs and their relation to active tuberculosis
Xu, Z., Zhou, A., Ni, J., Zhang, Q., Wang, Y., Lu, J., Wu, W., Karakousis, P. C., Lu, S., & Yao, Y. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.02.043 · Cited by 36
Role of noncoding RNA in vascular remodelling
Deng, L., Bradshaw, A. C., & Baker, A. H. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000336 · Cited by 36
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection
Russell, J. S., Toit, E. F. D., Peart, J. N., Patel, H. H., & Headrick, J. P. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0638-z · Cited by 37
Hepatic miR‐125b inhibits insulin signaling pathway by targeting PIK3CD
Du, X., Li, X., Chen, L., Zhang, M., Lei, L., Gao, W., Shi, Z., Dong, Y., Wang, Z., Li, X., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26442 · Cited by 37
The Destiny of Glucose from a MicroRNA Perspective
Mirra, P., Nigro, C., Prevenzano, I., Leone, A., Raciti, G. A., Formisano, P., Bèguinot, F., & Miele, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00046 · Cited by 40
microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
Langlet, F., Tarbier, M., Haeusler, R. A., Camastra, S., Ferrannini, E., Friedländer, M. R., & Accili, D. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.003 · Cited by 38
Circulating miRNAs Associated with Arsenic Exposure
Beck, R., Bommarito, P. A., Douillet, C., Kanke, M., Razo, L. M. D., García-Vargas, G. G., Fry, R. C., Sethupathy, P., & Stýblo, M. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b06457 · Cited by 36
Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1
Xiong, Y., Liu, Z., Li, Z., Wang, S., Shen, N., Yue, X., & Huang, T. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4869 · Cited by 36
Circulating miR-330-3p in Late Pregnancy is Associated with Pregnancy Outcomes Among Lean Women with GDM
Pfeiffer, S., Sánchez-Lechuga, B., Donovan, P., Halang, L., Prehn, J. H. M., Campos‐Caro, A., Byrne, M. M., & López‐Tinoco, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57838-6 · Cited by 39
Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Obesity
Nettore, I. C., Franchini, F., Palatucci, G., Macchia, P. E., & Ungaro, P. (2021) · Biomedicines · doi:10.3390/biomedicines9111716 · Cited by 39
Low Birth Weight Male Guinea Pig Offspring Display Increased Visceral Adiposity in Early Adulthood
Sarr, O., Thompson, J. A., Zhao, L., Lee, T., & Regnault, T. R. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098433 · Cited by 38
Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
Capuani, B., Pacifici, F., Della‐Morte, D., & Lauro, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00719 · Cited by 36
Epigenetics in Precision Nutrition
Li, X., & Qi, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040533 · Cited by 40
Site‐Directed RNA Editing with Antagomir Deaminases — A Tool to Study Protein and RNA Function
Vogel, P., & Stafforst, T. (2014) · ChemMedChem · doi:10.1002/cmdc.201402139 · Cited by 36
Regulation and mechanism of mouse miR-130a/b in metabolism-related inflammation
Zheng, H., Dong, X., Liu, N., Xia, W., Zhou, L., Chen, X., Yang, Z., & Chen, X. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.021 · Cited by 35
miR‐375 negatively regulates porcine preadipocyte differentiation by targeting BMPR 2
Liu, S., Sun, G., Yuan, B., Zhang, L., Gao, Y., Jiang, H., Dai, L., & Zhang, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12169 · Cited by 35
Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1
Wang, S., Ai, H., Liu, L., Zhang, X., Gao, F., Zheng, L., Yi, J., Sun, L., Yu, C., Zhao, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2019 · Cited by 36
First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
Hromadníková, I., Kotlabová, K., & Krofta, L. (2022) · Biomedicines · doi:10.3390/biomedicines10030718 · Cited by 36
A Review of micro RNAs changes in T2DM in animals and humans
Afsharmanesh, M. R., Mohammadi, Z., Mansourian, A. R., & Jafari, S. M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13431 · Cited by 39
miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease
Suksangrat, T., Phannasil, P., & Jitrapakdee, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_7 · Cited by 34
Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4
Luo, M., Xu, C., Luo, Y., Wang, G., Wu, J., & Wan, Q. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01430-6 · Cited by 34
RETRACTED ARTICLE: The Potential Role of Zinc Oxide Nanoparticles in MicroRNAs Dysregulation in STZ-Induced Type 2 Diabetes in Rats
Othman, M. S., Hafez, M. M., & Moneim, A. E. A. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-02012-x · Cited by 35
Retracted
Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
Seok, S., Sun, H., Kim, Y., KEMPER, B. W., & Kemper, J. K. (2020) · Diabetes · doi:10.2337/db20-0856 · Cited by 34
Personalized Nutrition Approach in Pregnancy and Early Life to Tackle Childhood and Adult Non-Communicable Diseases
Alabduljabbar, S., Zaidan, S. A., Lakshmanan, A. P., & Terranegra, A. (2021) · Life · doi:10.3390/life11060467 · Cited by 34
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?
Codocedo, J. F., Ríos, J. A., Godoy, J. A., & Inestrosa, N. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9201-7 · Cited by 34
let-7 Contributes to Diabetic Retinopathy but Represses Pathological Ocular Angiogenesis
Zhou, Q., Frost, R. J., Anderson, C. A., Zhao, F., Ma, J., Yu, B., & Wang, S. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-17 · Cited by 34
Post-transcriptional regulation in metabolic diseases
Kim, W., & Lee, E. K. (2012) · RNA Biology · doi:10.4161/rna.20091 · Cited by 33
A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells
Locke, J. M., Allen, H. L., & Harries, L. W. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0499-1 · Cited by 33
Fenofibrate reverses changes induced by high‐fat diet on metabolism in mice muscle and visceral adipocytes
Frias, F. D. T., Rocha, K. C. E., de Mendonça, M., Murata, G. M., Araújo, H. N., de Sousa, L. G. O., de Sousa, É., Hirabara, S. M., Leite, N. C., Carneiro, E. M., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26203 · Cited by 33
Nighttime light exposure enhances Rev-erbα-targeting microRNAs and contributes to hepatic steatosis
Borck, P. C., Batista, T. M., Vettorazzi, J. F., Soares, G. M., Lubaczeuski, C., Guan, D., Boschero, A. C., Vieira, E. C., Lazar, M. A., & Carneiro, E. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.05.002 · Cited by 33
Integrative roles of microRNAs in lipid metabolism and dyslipidemia
Sedgeman, L. R., Michell, D. L., & Vickers, K. C. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000603 · Cited by 33
MicroRNA 182 is a Novel Negative Regulator of Adipogenesis by Targeting CCAAT/Enhancer‐Binding Protein α
Dong, M., Ye, Y., Chen, Z., Xiao, T., Liu, W., & Hu, F. (2020) · Obesity · doi:10.1002/oby.22863 · Cited by 33
miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells
Toyoshima, S., Sakamoto-Sasaki, T., Kurosawa, Y., Hayama, K., Matsuda, A., Watanabe, Y., Terui, T., Gon, Y., Matsumoto, K., & Okayama, Y. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.002 · Cited by 33
Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced heart failure via sponging microRNA-103-3p
Zhang, X., Yuan, S., Liu, J., Tang, Y., Wang, Y., Zhan, J., Fan, J., Nie, X., Zhao, Y., Zheng, W., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.002 · Cited by 32
Integrated miRNA-mRNA analysis reveals the dysregulation of lipid metabolism in mouse liver induced by developmental arsenic exposure
Chen, X., Wu, R., Wu, H., Hu, Y., Wang, H. H., Fu, J., Pi, J., & Xu, Y. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130459 · Cited by 33
Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease
Li, Q., Freeman, L. M., Rush, J. E., & Laflamme, D. P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160614098 · Cited by 33
Down‐regulation of Risa improves insulin sensitivity by enhancing autophagy
Wang, Y., Hu, Y., Sun, C., Zhuo, S., He, Z., Wang, H., Yan, M., Liu, J., Luan, Y., Dai, C., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500058r · Cited by 33
Cafeteria Diet Consumption during Lactation in Rats, Rather than Obesity Per Se, alters miR‐222, miR‐200a, and miR‐26a Levels in Milk
Pomar, C. A., Castro, H., Picó, C., Serra, F. A., Palou, A., & Sánchez, J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800928 · Cited by 33
Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems
Spinetti, G., Mutoli, M., Greco, S., Riccio, F., Ben‐Aicha, S., Kenneweg, F., Jusić, A., de Gonzalo‐Calvo, D., Nossent, A. Y., Novella, S., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01842-3 · Cited by 38
MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells
Yang, W., Min, K.-H., & Lee, W. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.029 · Cited by 32
Adipose tissue development and the molecular regulation of lipid metabolism
Raajendiran, A., Tsiloulis, T., & Watt, M. J. (2016) · Essays in Biochemistry · doi:10.1042/ebc20160042 · Cited by 33
microRNAs as therapeutic targets in intestinal diseases
Wang, C., & Chen, J. (2019) · ExRNA · doi:10.1186/s41544-019-0026-9 · Cited by 33
Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential
Nie, X., Zhao, J., Ling, H., Deng, Y., Li, X., & He, Y. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15139 · Cited by 33
Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus—One of Several Possible Reasons for an Increased Cardiovascular Risk
Hromadníková, I., Kotlabová, K., Dvořáková, L., Krofta, L., & Širc, J. (2020) · Cells · doi:10.3390/cells9061557 · Cited by 32
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
Mehta, M., Satija, S., Paudel, K. R., Malyla, V., Kannaujiya, V. K., Chellappan, D. K., Bebawy, M., Hansbro, P. M., Wich, P. R., & Dua, K. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102303 · Cited by 32
MicroRNAs and Oxidative Stress: An Intriguing Crosstalk to Be Exploited in the Management of Type 2 Diabetes
Vezza, T., Marañón, A., Canet, F., Díaz-Pozo, P., Marti, M., D’Ocón, P., Apostolova, N., Rocha, M., & Víctor, V. M. (2021) · Antioxidants · doi:10.3390/antiox10050802 · Cited by 34
Expression levels of specific microRNAs are increased after exercise and are associated with cognitive improvement in Parkinson's disease
Silva, F. D., Rode, M. P., Vietta, G. G., Iop, R. D. R., Creczynski‐Pasa, T. B., Martin, A., & da Silva, R. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12257 · Cited by 32
Regulation of human adipogenesis by miR125b-5p
Rockstroh, D., Löffler, D., Kieß, W., Landgraf, K., & Körner, A. (2016) · Adipocyte · doi:10.1080/21623945.2016.1195044 · Cited by 33
Oligonucleotide therapies for nonalcoholic steatohepatitis
Li, S., Xiong, F., Zhang, S., Liu, J., Gao, G., Xie, J. H., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102184 · Cited by 32
Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC
Carpi, S., Daniele, S., de Almeida, J. F. M., & Gabbia, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212229 · Cited by 35
MicroRNAs in Liver Health and Disease
Hsu, S., & Ghoshal, K. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0005-4 · Cited by 32
Role of microRNAs on the Regulation of Mitochondrial Biogenesis and Insulin Signaling in Skeletal Muscle
de Lima, T. I., Araújo, H. N., Menezes, E. S., Sponton, C. H., de Araújo, M. B., Bomfim, L. H. M., Queiroz, A. L., Passos, M. A., Sousa, T. A. E., Hirabara, S. M., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25645 · Cited by 34
MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus
Matsha, T. E., Kengne, A. P., Hector, S. B., Mbu, D. L., Yako, Y. Y., & Erasmus, R. T. (2018) · Oncotarget · doi:10.18632/oncotarget.25271 · Cited by 31
MicroRNAs and type 2 diabetes
Deng, J., & Guo, F. (2019) · ExRNA · doi:10.1186/s41544-019-0038-5 · Cited by 31
Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications
Asakiya, C., Zhu, L., Yuhan, J., Zhu, L., Huang, K., & Xu, W. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2063835 · Cited by 31
Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications
Hromadníková, I., Kotlabová, K., & Krofta, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810635 · Cited by 35
Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview
Palihaderu, P. A. D. S., Mendis, B. S. S., Premarathne, J. M. K. J. K., Dias, W., Yeap, S. K., Ho, W. Y., Dissanayake, A., Rajapakse, I. H., Karunanayake, P., Senarath, U., et al. (2022) · Epigenetics Insights · doi:10.1177/25168657221130041 · Cited by 33
MicroRNAs: New Insights into Chronic Childhood Diseases
Omran, A. G., Elimam, D., & Yin, F. (2013) · BioMed Research International · doi:10.1155/2013/291826 · Cited by 32
Far-off and close-up dry matter intake modulate indicators of immunometabolic adaptations to lactation in subcutaneous adipose tissue of pasture-based transition dairy cows
Vailati-Riboni, M., Farina, G., Batistel, F., Heiser, A., Mitchell, M. D., Crookenden, M. A., Walker, C. G., Kay, J. K., Meier, S., Roche, J. R., et al. (2017) · Journal of Dairy Science · doi:10.3168/jds.2016-11790 · Cited by 31
Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus
Mannar, V., Boro, H., Patel, D., Agstam, S., Dalvi, M., & Bundela, V. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.46 · Cited by 38
MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases
Alrob, O. A., Khatib, S. Y., & Naser, S. A. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0543-z · Cited by 31
Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
Escutia-Gutiérrez, R., Rodríguez-Sanabria, J. S., Monraz-Méndez, C. A., Garcia-Bañuelos, J. J., Santos, A., Sandoval-Rodriguez, A. S., & Armendáriz‐Borunda, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91187-2 · Cited by 31
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
Romeo, M., Dallio, M., Scognamiglio, F., Ventriglia, L., Cipullo, M., Coppola, A., Tammaro, C., Scafuro, G., Iodice, P., & Federico, A. (2023) · Cancers · doi:10.3390/cancers15215178 · Cited by 32
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health
Micó, V., Díez-Ricote, L., & Daimiel, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030299 · Cited by 30
Regulation of HDL Genes: Transcriptional, Posttranscriptional, and Posttranslational
Kardassis, D., Gafencu, A. V., Zannis, V. I., & Dávalos, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_3 · Cited by 30
Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance
Galimov, A., Hartung, A., Trepp, R., Mader, A., Flück, M., Linke, A., Blüher, M., Christ, E., & Krützfeldt, J. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1322-y · Cited by 30
Time and dose-dependent effects of phenobarbital on the rat liver miRNAome
Koufaris, C., WRIGHT, J. A., Osborne, M., Currie, R. A., & Gooderham, N. J. (2013) · Toxicology · doi:10.1016/j.tox.2013.10.004 · Cited by 30
Circulating miRNAs as Intercellular Messengers, Potential Biomarkers and Therapeutic Targets for Type 2 Diabetes
Mirra, P., Raciti, G. A., Nigro, C., Fiory, F., D’Esposito, V., Formisano, P., Bèguinot, F., & Miele, C. (2015) · Epigenomics · doi:10.2217/epi.15.18 · Cited by 30

Authors: Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
Affiliations: ETH Zurich (CH)
University of Basel (CH)
Regulus Therapeutics (United States) (US)
University Hospital of Basel (CH)
Corresponding author: Stoffel, Markus
ORCID: Trajkovski, Mirko
Hausser, Jean
Zavolan, Mihaela
Heim, Markus H.
Stoffel, Markus
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-06
Volume: 474
Issue: 7353
Pages: 649-653
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10112
OpenAlex: W2075317528
Cited by: 1,000
References: 27
Citations by year: 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
FWCI: 25.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
RePEc: Research Papers in Economics (submittedVersion)
BIROn (Birkbeck, University of London) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders: National Science Foundation
Juvenile Diabetes Research Foundation International
Fondation Leducq
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
MeSH terms: Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNAs 103 and 107 regulate insulin sensitivity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks